3

$AMGN · Amgen Inc.

October 27, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

On October 26, 2026, David W. Gibbs filed a Form 3 with the Securities and Exchange Commission for Amgen Inc. A Form 3 is an initial statement of beneficial ownership that company insiders must file when they take on a role such as director or officer. The filing identifies Gibbs as a director of Amgen and lists his address as One Amgen Center Drive in Thousand Oaks, California.

The filing states that Gibbs does not beneficially own any securities of Amgen. Both the table for non-derivative securities and the table for derivative securities are blank, and an explanatory note says, “No securities are beneficially owned.” The form was signed by Gibbs on October 26, 2026. This filing is a routine ownership disclosure tied to his new role as a director, not a purchase, sale, or other transaction.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →